
    
      This will be an open-label, prospective survey study of patients who previously underwent
      cataract surgery with the Alcon PanOptix or PanOptix Toric intraocular lens in both eyes,
      comparing to an existing historical dataset of patient reported outcomes with bilateral
      ReSTOR 3.0 implants.
    
  